Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
| 09-2025 | 08-2025 | 05-2025 | 02-2025 | 11-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,991 | -9,991 | N/A | -37,570 | -22,801 |
| Depreciation Amortization | 1,981 | 1,981 | N/A | 6,113 | 4,037 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 9 |
| Accounts receivable | -4,575 | -4,575 | N/A | -602 | 1,000 |
| Accounts payable and accrued liabilities | 2,256 | 2,256 | N/A | -2,714 | 791 |
| Other Working Capital | 638 | 638 | N/A | -3,669 | -1,229 |
| Other Operating Activity | 11,453 | 11,453 | 0 | 32,889 | 11,440 |
| Operating Cash Flow | $1,762 | $1,762 | $N/A | $-5,553 | $-6,753 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,737 | -1,737 | N/A | -4,318 | -5,862 |
| Investing Cash Flow | $-1,737 | $-1,737 | $N/A | $-4,318 | $-5,862 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 12,100 | 12,100 | N/A | -17,191 | -11,191 |
| Debt Issued | N/A | N/A | N/A | 2,400 | 2,400 |
| Debt Repayment | -232 | -232 | N/A | -699 | -468 |
| Common Stock Issued | N/A | N/A | N/A | 23,858 | 23,841 |
| Other Financing Activity | -13,256 | -13,256 | 0 | -1,542 | -974 |
| Financing Cash Flow | $-1,388 | $-1,388 | $N/A | $6,826 | $13,608 |
| Beginning Cash Position | 20,219 | 20,219 | N/A | 8,462 | 8,462 |
| End Cash Position | 18,856 | 18,856 | N/A | 5,417 | 9,455 |
| Net Cash Flow | $-1,363 | $-1,363 | $N/A | $-3,045 | $993 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,762 | 1,762 | N/A | -5,553 | -6,753 |
| Capital Expenditure | -1,737 | -1,737 | N/A | -11,318 | -5,862 |
| Free Cash Flow | 25 | 25 | 0 | -16,871 | -12,615 |